https://orcid.org/0000-0003-0169-9899
References
- Hadrup N, Lam HR. Oral toxicity of silver ions, silver nanoparticles and colloidal silver – a review. Regul Toxicol Pharmacol. 2014;68(1):1–7.
- Mao BH, Chen ZY, Wang YJ, et al. Silver nanoparticles have lethal and sublethal adverse effects on development and longevity by inducing ROS-mediated stress responses. Sci Rep. 2018;8(1):2445.
- Li Y, Cummins E. Hazard characterization of silver nanoparticles for human exposure routes. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2020;55(6):704–725.
- Roda E, Bottone MG, Biggiogera M, et al. Pulmonary and hepatic effects after low dose exposure to nanosilver: early and long-lasting histological and ultrastructural alterations in rat. Toxicol Rep. 2019;6:1047–1060.
- Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, et al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol. 2012;32(11):920–928.
- Aylward LL, Bachler G, von Goetz N, et al. Biomonitoring equivalents for interpretation of silver biomonitoring data in a risk assessment context. Int J Hyg Environ Health. 2016;219(6):521–526.
- Savery LC, Vinas R, Nagy AM, et al. Deriving a provisional tolerable intake for intravenous exposure to silver nanoparticles released from medical devices. Regul Toxicol Pharmacol. 2017;85:108–118.
- Skvortsov AN, Il'icheva E, Zatulovskii EA, et al. [Characteristics of rat ceruloplasmin from the serum of animals, which received salts of silver with food]. Tsitologiia. 2010;52(11):960–966.
- Lee J, Pena MM, Nose Y, et al. Biochemical characterization of the human copper transporter Ctr1. J Biol Chem. 2002;277(6):4380–4387.
- Stepien KM, Taylor A. Colloidal silver ingestion with copper and caeruloplasmin deficiency. Ann Clin Biochem. 2012;49(Pt 3):300–301.
- Tran HA, Song S. Silver toxicity masquerading as hypocaeruloplasminaemia. Pathology. 2007;39(4):456–458.
- Parang Z, Moghadamnia D. Effects of silver nanoparticles on the functional tests of liver and its histological changes in adult male rats. Nanomed Res J. 2018;3(3):146–153.
- Pelucchi S, Mariani R, Ravasi G, et al. Phenotypic heterogeneity in seven Italian cases of aceruloplasminemia. Parkinsonism Relat Disord. 2018;51:36–42.
- Tang J, Xiong L, Zhou G, et al. Silver nanoparticles crossing through and distribution in the blood–brain barrier in vitro. J Nanosci Nanotechnol. 2010;10(10):6313–6317.
- Tang J, Xiong L, Wang S, et al. Distribution, translocation and accumulation of silver nanoparticles in rats. J Nanosci Nanotechnol. 2009;9(8):4924–4932.
- Dietl HW, Anzil AP, Mehraein P. Brain involvement in generalized argyria. Clinical Neuropathology 1984;3(1):32–36.
- Hadrup N, Loeschner K, Mortensen A, et al. The similar neurotoxic effects of nanoparticulate and ionic silver in vivo and in vitro. Neurotoxicology. 2012;33(3):416–423.
- Hadrup N, Sharma AK, Loeschner K, et al. Pulmonary toxicity of silver vapours, nanoparticles and fine dusts: a review. Regul Toxicol Pharmacol. 2020;115:104690.
- East BW, Boddy K, Williams ED, et al. Silver retention, total body silver and tissue silver concentrations in argyria associated with exposure to an anti-smoking remedy containing silver acetate. Clin Exp Dermatol. 1980;5(3):305–311.
- DiVincenzo GD, Giordano CJ, Schriever LS. Biologic monitoring of workers exposed to silver. Int Arch Occup Environ Health. 1985;56(3):207–215.
- Newton D, Holmes A. A case of accidental inhalation of zinc-65 and silver-110m. Radiat Res. 1966;29(3):403–412.
- Mendonca MCP, Ferreira LB, Rizoli C, et al. N-Acetylcysteine reverses silver nanoparticle intoxication in rats. Nanotoxicology. 2019;13(3):326–338.